Clinical Trial Research
Pharmos Corporation Reports 2009 Second Quarter Results
Published in Drug Week, August 28th, 2009
Second Quarter Ended June 30, 2009
The Company recorded a net loss of $2.3 million, or $0.05 per share, for the second quarter 2009 compared to a net loss of $2.7 million, or $0.10 per share, in the second quarter 2008. Cash and cash equivalents totaled $2.9 million at June 30, 2009.
The decrease in net loss for the second quarter 2009 is due primarily to a 38% decrease in operating expenses to $1.6 million from $2.6 million in the second quarter 2008. The decline in operating expenses resulted from a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2009-08-28)
More Articles from Drug Week
- Alcoholism
A synthetic derivative of the kudzu vine can reduce drinking and prevent relapse - American Association for Cancer Research
Budesonide is not beneficial for the treatment of diarrhea in metastatic melanoma patients - American Dietetic Association
ADA publishes practice guidelines for nutrition care for patients with spinal cord injury - American Thoracic Society
Misuse of common antibiotic is creating resistant TB - JAMA and Archives Journals
Aspirin use after colorectal cancer diagnosis associated with improved survival - Johns Hopkins University Bloomberg School of Public Health
Guided care reduces cost of health care for older persons with chronic conditions - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
